Cita APA

Fiascarelli, A., Merlino, G., Capano, S., Talucci, S., Bisgnano, D., Bressan, A., . . . Binaschi, M. (2023). Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer.

Citación estilo Chicago

Fiascarelli, Alessio, et al. Antitumor Activity of the PI3K δ-sparing Inhibitor MEN1611 in PIK3CA Mutated, Trastuzumab-resistant HER2 + Breast Cancer. 2023.

Cita MLA

Fiascarelli, Alessio, et al. Antitumor Activity of the PI3K δ-sparing Inhibitor MEN1611 in PIK3CA Mutated, Trastuzumab-resistant HER2 + Breast Cancer. 2023.